These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32157189)

  • 41. A novel GBA2 gene missense mutation in spastic ataxia.
    Votsi C; Zamba-Papanicolaou E; Middleton LT; Pantzaris M; Christodoulou K
    Ann Hum Genet; 2014 Jan; 78(1):13-22. PubMed ID: 24252062
    [TBL] [Abstract][Full Text] [Related]  

  • 42. De novo variants in POLR3B cause ataxia, spasticity, and demyelinating neuropathy.
    Djordjevic D; Pinard M; Gauthier MS; Smith-Hicks C; Hoffman TL; Wolf NI; Oegema R; van Binsbergen E; Baskin B; Bernard G; Fribourg S; Coulombe B; Yoon G
    Am J Hum Genet; 2021 Jan; 108(1):186-193. PubMed ID: 33417887
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A potential gain-of-function variant of SLC9A6 leads to endosomal alkalinization and neuronal atrophy associated with Christianson Syndrome.
    Ilie A; Gao AYL; Boucher A; Park J; Berghuis AM; Hoffer MJV; Hilhorst-Hofstee Y; McKinney RA; Orlowski J
    Neurobiol Dis; 2019 Jan; 121():187-204. PubMed ID: 30296617
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay.
    Machol K; Rousseau J; Ehresmann S; Garcia T; Nguyen TTM; Spillmann RC; Sullivan JA; Shashi V; Jiang YH; Stong N; Fiala E; Willing M; Pfundt R; Kleefstra T; Cho MT; McLaughlin H; Rosello Piera M; Orellana C; Martínez F; Caro-Llopis A; Monfort S; Roscioli T; Nixon CY; Buckley MF; Turner A; Jones WD; van Hasselt PM; Hofstede FC; van Gassen KLI; Brooks AS; van Slegtenhorst MA; Lachlan K; Sebastian J; Madan-Khetarpal S; Sonal D; Sakkubai N; Thevenon J; Faivre L; Maurel A; Petrovski S; Krantz ID; Tarpinian JM; Rosenfeld JA; Lee BH; ; Campeau PM
    Am J Hum Genet; 2019 Jan; 104(1):164-178. PubMed ID: 30580808
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ATP2B2 de novo variants as a cause of variable neurodevelopmental disorders that feature dystonia, ataxia, intellectual disability, behavioral symptoms, and seizures.
    Poggio E; Barazzuol L; Salmaso A; Milani C; Deligiannopoulou A; Cazorla ÁG; Jang SS; Juliá-Palacios N; Keren B; Kopajtich R; Lynch SA; Mignot C; Moorwood C; Neuhofer C; Nigro V; Oostra A; Prokisch H; Saillour V; Schuermans N; Torella A; Verloo P; Yazbeck E; Zollino M; Jech R; Winkelmann J; Necpal J; Calì T; Brini M; Zech M
    Genet Med; 2023 Dec; 25(12):100971. PubMed ID: 37675773
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification and functional analysis of two new de novo KCNMA1 variants associated with Liang-Wang syndrome.
    Liang L; Liu H; Bartholdi D; van Haeringen A; Fernandez-Jaén A; Peeters EEA; Xiong H; Bai X; Xu C; Ke T; Wang QK
    Acta Physiol (Oxf); 2022 May; 235(1):e13800. PubMed ID: 35156297
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
    Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
    Mol Autism; 2019; 10():35. PubMed ID: 31649809
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel de novo heterozygous loss-of-function variants in MED13L and further delineation of the MED13L haploinsufficiency syndrome.
    Cafiero C; Marangi G; Orteschi D; Ali M; Asaro A; Ponzi E; Moncada A; Ricciardi S; Murdolo M; Mancano G; Contaldo I; Leuzzi V; Battaglia D; Mercuri E; Slavotinek AM; Zollino M
    Eur J Hum Genet; 2015 Nov; 23(11):1499-504. PubMed ID: 25712080
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Focal segmental glomerulosclerosis and mild intellectual disability in a patient with a novel de novo truncating TRIM8 mutation.
    McClatchey MA; du Toit ZD; Vaughan R; Whatley SD; Martins S; Hegde S; Naude JTW; Thomas DH; Griffiths DF; Genomics England Research Consortium ; Clarke AJ; Fry AE
    Eur J Med Genet; 2020 Sep; 63(9):103972. PubMed ID: 32531461
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pyruvate dehydrogenase deficiency in 35 patients.
    Blass JP; Cederbaum SD; Kark RA; Rodriguez-Budelli M
    Monogr Hum Genet; 1978; 9():12-5. PubMed ID: 104145
    [No Abstract]   [Full Text] [Related]  

  • 51. Truncating Variants in NAA15 Are Associated with Variable Levels of Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies.
    Cheng H; Dharmadhikari AV; Varland S; Ma N; Domingo D; Kleyner R; Rope AF; Yoon M; Stray-Pedersen A; Posey JE; Crews SR; Eldomery MK; Akdemir ZC; Lewis AM; Sutton VR; Rosenfeld JA; Conboy E; Agre K; Xia F; Walkiewicz M; Longoni M; High FA; van Slegtenhorst MA; Mancini GMS; Finnila CR; van Haeringen A; den Hollander N; Ruivenkamp C; Naidu S; Mahida S; Palmer EE; Murray L; Lim D; Jayakar P; Parker MJ; Giusto S; Stracuzzi E; Romano C; Beighley JS; Bernier RA; Küry S; Nizon M; Corbett MA; Shaw M; Gardner A; Barnett C; Armstrong R; Kassahn KS; Van Dijck A; Vandeweyer G; Kleefstra T; Schieving J; Jongmans MJ; de Vries BBA; Pfundt R; Kerr B; Rojas SK; Boycott KM; Person R; Willaert R; Eichler EE; Kooy RF; Yang Y; Wu JC; Lupski JR; Arnesen T; Cooper GM; Chung WK; Gecz J; Stessman HAF; Meng L; Lyon GJ
    Am J Hum Genet; 2018 May; 102(5):985-994. PubMed ID: 29656860
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurological Phenotypes Associated with AAAS-Related Disorders: Spastic Ataxia and Complex Spastic Paraplegia.
    Lorea CF; Tenório RB; Koenig M; Huebner A; Koehler K; Devos D; Guissart C; Saute JAM
    Cerebellum; 2020 Jun; 19(3):465-468. PubMed ID: 32146693
    [No Abstract]   [Full Text] [Related]  

  • 53. De novo variants in FRMD5 are associated with developmental delay, intellectual disability, ataxia, and abnormalities of eye movement.
    Lu S; Ma M; Mao X; Bacino CA; Jankovic J; Sutton VR; Bartley JA; Wang X; Rosenfeld JA; Beleza-Meireles A; Chauhan J; Pan X; Li M; Liu P; Prescott K; Amin S; Davies G; Wangler MF; Dai Y; Bellen HJ
    Am J Hum Genet; 2022 Oct; 109(10):1932-1943. PubMed ID: 36206744
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutations in the BAF-Complex Subunit DPF2 Are Associated with Coffin-Siris Syndrome.
    Vasileiou G; Vergarajauregui S; Endele S; Popp B; Büttner C; Ekici AB; Gerard M; Bramswig NC; Albrecht B; Clayton-Smith J; Morton J; Tomkins S; Low K; Weber A; Wenzel M; Altmüller J; Li Y; Wollnik B; Hoganson G; Plona MR; Cho MT; ; Thiel CT; Lüdecke HJ; Strom TM; Calpena E; Wilkie AOM; Wieczorek D; Engel FB; Reis A
    Am J Hum Genet; 2018 Mar; 102(3):468-479. PubMed ID: 29429572
    [TBL] [Abstract][Full Text] [Related]  

  • 55. De novo missense variants in HECW2 are associated with neurodevelopmental delay and hypotonia.
    Berko ER; Cho MT; Eng C; Shao Y; Sweetser DA; Waxler J; Robin NH; Brewer F; Donkervoort S; Mohassel P; Bönnemann CG; Bialer M; Moore C; Wolfe LA; Tifft CJ; Shen Y; Retterer K; Millan F; Chung WK
    J Med Genet; 2017 Feb; 54(2):84-86. PubMed ID: 27389779
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification and functional characterization of de novo FOXP1 variants provides novel insights into the etiology of neurodevelopmental disorder.
    Sollis E; Graham SA; Vino A; Froehlich H; Vreeburg M; Dimitropoulou D; Gilissen C; Pfundt R; Rappold GA; Brunner HG; Deriziotis P; Fisher SE
    Hum Mol Genet; 2016 Feb; 25(3):546-57. PubMed ID: 26647308
    [TBL] [Abstract][Full Text] [Related]  

  • 57. KCNC1-related disorders: new de novo variants expand the phenotypic spectrum.
    Park J; Koko M; Hedrich UBS; Hermann A; Cremer K; Haberlandt E; Grimmel M; Alhaddad B; Beck-Woedl S; Harrer M; Karall D; Kingelhoefer L; Tzschach A; Matthies LC; Strom TM; Ringelstein EB; Sturm M; Engels H; Wolff M; Lerche H; Haack TB
    Ann Clin Transl Neurol; 2019 Jul; 6(7):1319-1326. PubMed ID: 31353862
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel mutation in the GATAD2B gene associated with severe intellectual disability.
    Ueda K; Yanagi K; Kaname T; Okamoto N
    Brain Dev; 2019 Mar; 41(3):276-279. PubMed ID: 30482549
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Familial distal monosomy 3p26.3-pter with trisomy 4q32.2-qter, presenting with progressive ataxia, intellectual disability, and dysmorphic features.
    Petriczko E; Biczysko-Mokosa A; Bogdanowicz J; Constantinou M; Zdziennicka E; Horodnicka-Jozwa A; Barg E; Gawlik-Zawislak S; Sulek-Piatkowska A; Dawid G; Walczak M; Pesz K; Kedzia A; Zajaczek S
    Am J Med Genet A; 2012 Jun; 158A(6):1442-6. PubMed ID: 22581569
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Establishing SON in 21q22.11 as a cause a new syndromic form of intellectual disability: Possible contribution to Braddock-Carey syndrome phenotype.
    Takenouchi T; Miura K; Uehara T; Mizuno S; Kosaki K
    Am J Med Genet A; 2016 Oct; 170(10):2587-90. PubMed ID: 27256762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.